혈우병연구회 2023년 동아시아 혈우병 포럼(4월 6일) - 1일차 : 2023-04-06
교육일자 : 2023-04-06
교육장소 : 앰버서더 서울 풀만호텔

교육주제 : 2023년 동아시아 혈우병 포럼(4월 6일) - 1일차

주최기관 : 대한혈액학회
시행기관(지부/과) : 혈우병연구회

담당자 : 김혜진
연락처 : 02-516-6581

이메일 : hematology@kams.or.kr

교육종류 : 내과, 소아청소년과, 진단검사의학과

참석예상인원 : 200명
희망평점 : 6점

지역 : 서울특별시
교육시간 : 7 시간 0분

세부수강료 : 80,000원  

비고 전공의,간호사,기타 50000원

구분 월일 강의실 시간 교육제목 강사명(소속) 필수과목

교육시간 04-06 그랜드볼룸 09:15~09:35 Current status of hemophilia care in China Renchi Yang(Institute of Haematology and Blood Diseases Hospital, China)

교육시간 04-06 그랜드볼룸 09:35~09:55 Current Situation and Issues in Hemophilia in Japan Michio Sakai(Munakata Suikokai General Hospital, Japan)

교육시간 04-06 그랜드볼룸 09:55~10:15 Current Situation and Issues in Hemophilia in Korea Ki-Young Yoo(Korea Hemophilia Foundation, Korea)

교육시간 04-06 그랜드볼룸 10:15~10:35 Current Situation and Issues in Hemophilia in Taiwan Chia-Yao Chang(Taipei Medical University Hospital, Taiwan)

교육시간 04-06 그랜드볼룸 10:35~10:55 Current therapeutic landscape and future directions in the management of haemophilia in Australia Huyen Tran(Australia Haemophilia Centre Directors)

교육시간 04-06 그랜드볼룸 11:20~12:00 Advances in hemophilia A treatment after emicizumab Midori Shima(Thrombosis and Hemostasis Research Center, Japan)

교육시간 04-06 그랜드볼룸 12:10~12:50 Optimizing the benefits of personalized prophylaxis based on the real world experience Robert Klamroth(Vivantes Klinikum Friedrichshain, Germany)

교육시간 04-06 그랜드볼룸 13:00~13:20 Emicizumab for Individual Needs of Japanese People Living with Hemophilia: Impacts and Unsolved Issues Ei Kinai(Tokyo Medical University, Japan)

교육시간 04-06 그랜드볼룸 13:20~13:40 The role of low-dose prophylaxis and low-dose ITI for hemophilia children in developing countries. Runhui Wu(Beijing Children’s Hospital, China)

교육시간 04-06 그랜드볼룸 13:40~14:00 Individualized Treatment Using Population Pharmacokinetics for Patients with Hemophilia in Taiwan Yeu-Chin Chen(Tri-Service General Hospital, Taiwan)

교육시간 04-06 그랜드볼룸 14:00~14:20 Current treatment pattern in hemophilia, based upon data the HIRA(health insurance review agency) and KBDR (Korean bleeding disorder registry) Jung Woo Han(Yonsei University Health System, Korea)

교육시간 04-06 그랜드볼룸 14:45~15:05 Hemophilia patients with Inhibitors in China Wei Liu(Blood Diseases Hospital (Institute of Hematology), China)

교육시간 04-06 그랜드볼룸 15:05~15:25 The frontiers of diagnosis and treatment in Japanese hemophilia patients with inhibitors based on prospective cohort study in Japan, J-HIS2 (Japan Hemophilia Inhibitor Study 2) Koji Yada(National Hospital Organization Osaka National Hospital, Japan)

교육시간 04-06 그랜드볼룸 15:25~15:45 Current status in hemophilia patients with inhibitors in Korea YoungShil Park(Kyung Hee University Hospital, Korea)

교육시간 04-06 그랜드볼룸 15:45~16:05 Efficacy, safety, and cost of emicizumab prophylaxis in hemophilia A patients with inhibitor: a nationwide observation study in Taiwan Jiaan-Der Wang(Taichung Veterans General Hospital, Taiwan)

교육시간 04-06 그랜드볼룸 16:30~16:50 Clinical hemostasis prediction through current monitoring technology in bleeding disorders Naruto Shimonishi(Nara Medical University, Japan)

교육시간 04-06 그랜드볼룸 16:50~17:10 The application of NGS for the diagnosis of hereditary platelet disorders Donglei Zhang(Zhongnan Hospital of Wuhan University, China)

교육시간 04-06 그랜드볼룸 17:10~17:30 Laboratory monitor of factor VIII: perceive in the era of emicizumab Te-Fu Weng(Chung Shan Medical University Hospital, Taiwan)

교육시간 04-06 그랜드볼룸 17:30~17:50 Application of primary data of coagulometer assays Jae Woo Song(Yonsei University Health System, Korea)